您的位置: 首页 > 农业专利 > 详情页

Matrix metalloproteinase inhibitors
专利权人:
Ranbaxy Laboratories Limited
发明人:
Viswajanani J. Sattigeri,Venkata P. Palle,Manoj Kumar Khera,Ranadheer Reddy,Manoj Kumar Tiwari,Ajay Soni,Abdul Rehman Abdul Rauf,Sony Joseph,Arpita Musib,Sunanda G. Dastidar,Punit Kumar Srivastava
申请号:
US13936439
公开号:
US08846910B2
申请日:
2013.07.08
申请国别(地区):
US
年份:
2014
代理人:
摘要:
The present invention relates to β-hydroxy and amino-substituted carboxylic acids, which act as matrix metalloproteinase inhibitors, particularly diastereomerically pure β-hydroxy carboxylic acids, corresponding processes for their synthesis, and pharmaceutical compositions containing the compounds of the present invention. Compounds of the present invention are useful in the treatment of various inflammatory, autoimmune, and allergic diseases, such as methods of treating asthma, rheumatoid arthritis, COPD, rhinitis, osteoarthritis, psoriatic arthritis, psoriasis, pulmonary fibrosis, wound healing disorders, pulmonary inflammation, acute respiratory distress syndrome, perodontitis, multiple sclerosis, gingivitis, atherosclerosis, neointimal proliferation, which leads to restenosis and ischemic heart failure, stroke, renal diseases, tumor metastasis, and other inflammatory disorders characterized by the over-expression and over-activation of a matrix metalloproteinase.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充